Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: "Since the beginning of the epidemic, stigma, discrimination and gender inequality have been identified as major causes...
The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and deadly illnesses began to overwhelm medical centers across North America.
A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women had low prescription rates across all age groups. Medscape Medical News
Several giant US and international groups focused on fighting HIV and AIDS on Tuesday unveiled a plan to swiftly provide affordable access to a possibly "game-changing" HIV prevention drug in lower-income countries.
On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-U.S. (IAS-U.S.) has published new international guidelines for the treatment and prevention of HIV. The updated recommendations...
Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to stabilize plaques and prevent their rupture in blood...
Around 846 million people aged between 15 and 49 are living with genital herpes infections – more than 1 in 5 of this age-group globally – according to new estimates released today.
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, according to the results of an...
Burnet researchers and their collaborators have gained new insights into some of the underlying socio-behavioral and biological factors contributing to the alarmingly high rates of HIV and sexually transmitted infections (STIs) among...
Modern therapies help people living with HIV to survive, but scientists are still trying to decipher the deep mystery of how to eventually eradicate the virus for good. Now new laboratory work in Canada sheds light on the vulnerabilities...
Considerable scale-up is needed to achieve the 2025 goals for HIV preexposure prophylaxis (PrEP), according to research published in the Nov. 28 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly...
The UNAIDS report shows that Indonesia recorded 540,000 HIV cases as of 2023. That year saw a record high of 57,299 new HIV cases, with 5.5% (3,151) of these cases affecting adolescents aged 15–19.
With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ambitious goal: finding a cure for HIV/Aids.
The number of new HIV infections has fallen over the years—it declined by 39% from 2010 to 2023. But HIV's devastating impact on global health persists. In 2023, 1.3 million people acquired HIV—three times more than the 370,000 target...
Schulich School of Medicine & Dentistry researchers are on the cutting-edge of the study of HIV, working toward treatments and a better understanding of how the virus works.
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor's visits every three months and—most importantly—consistency.
The latest World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with tuberculosis (TB) in 2023, the highest number since the...
Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations said Tuesday, warning that this decline was still far too slow.
The Institute for Health Metrics and Evaluation (IHME) has published a new study in The Lancet HIV journal that revealed significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate...
A recent study by researchers from the Institute for Implementation Science in Population Health at CUNY SPH suggests that fatalistic attitudes among Kenyan truck drivers may undermine the potential benefits of HIV self-testing (HIVST)...
The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million - over four times the total number in 1990, according to findings from a global analysis published ahead of World Diabetes...
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment within affected neighborhoods.
The supply of health care professionals available to provide HIV care continues to decline, even as the need for HIV care and prevention is expected to increase, reports a survey study in the November/December issue of the Journal of the...
A University of Minnesota Medical School research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an important first step in optimizing brain development.
A clinical trial sponsored by the National Institutes of Health (NIH) has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir. This "on-demand" HIV...
Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene that could have prevented their vaccine from working in humans.
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some HIV-positive individuals, known as viremic non-progressors (VNPs), to avoid disease progression without antiretroviral...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, say global health specialists.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has proven highly effective in human trials, say global health specialists.
Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated cases. However, challenges remain, especially among migrant populations and recent arrivals.
Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without access to life-saving medicines and prevention tools.
Sweden has reached the UNAIDS and WHO targets for the HIV epidemic, according to a study in Eurosurveillance by researchers at Karolinska Institutet and others. According to the researchers, Sweden is the first country in the world to...
Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without access to life-saving medicines and prevention tools.
The U.S. Centers for Disease Control and Prevention (CDC) and the President's Emergency Plan for AIDS Relief (PEPFAR), have awarded $27.5 million to the Center for Global Health Practice and Impact (CGHPI) at Georgetown University...
It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus, a new study shows. Survival rates...
A survey of over half a million people in low- and middle-income countries found that men and women with disabilities were 25% less likely to have comprehensive knowledge about HIV prevention compared to people without disabilities. They...
A comprehensive national effort to improve the uptake of cervical screening among women living with HIV in Uganda resulted in more than 280,000 screening visits in the second year of the campaign, up from just 6500 visits in the first...
The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found. But the risk of having unsuppressed HIV one...
The majority of people who develop low-level viral load on dolutegravir resuppress viral load without needing to change treatment, a large Nigerian study has found, confirming observations regarding the frequency of viral load...
A mutation that can undermine two-drug treatment with dolutegravir and lamivudine persists for at least 12 years in the ‘archive’ of HIV locked up in the DNA of blood cells in one in three people, French researchers report. Their study...
Clinical education should teach a broader understanding of respectful clinical care for racialised women living with HIV from low-income backgrounds, an American study finds. While respecting patient autonomy is important, a singular...
The proportion of people with HIV who remain engaged with HIV care has declined over the years since HIV treatment began to be recommended for all people living with HIV, according to a retrospective cohort study published recently in...
A study designed to find out whether it is necessary or even desirable to test and treat gay and bisexual male and trans-female PrEP users for the bacterial STIs chlamydia or gonorrhoea every three months has produced an inconclusive...